| Jessica Paige Mullens, | |
|
302 University Pl, Durant, OK 74701-7110 | |
| (580) 920-1145 | |
| Not Available |
| Full Name | Jessica Paige Mullens |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 302 University Pl, Durant, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043790025 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 18006 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Paige Mullens, 302 University Pl, Durant, OK 74701-7110 Ph: () - | Jessica Paige Mullens, 302 University Pl, Durant, OK 74701-7110 Ph: (580) 920-1145 |
News Archive
Maxim's dedicated flu Web site provides detailed information about the flu vaccination and allows consumers to locate seasonal flu clinics in their area by searching by zip code. In addition, Maxim is preparing to launch several new online resources for consumers to protect themselves and their families this flu season.
Harnessing a probe used to image the brain in diagnosing Alzheimer's disease and related forms of dementia, scientists at Dana-Farber Cancer Institute and Massachusetts General Hospital have successfully cleared patient-derived brain cells of an abnormal protein associated with dementia and other neurogenerative disorders.
An article published in Nature Medicine with the collaboration of the research group of Dr. Manel Esteller, director of the Epigenetics and Cancer Biology Program of the Bellvitge Biomedical Research Institute, ICREA Researcher and Professor of Genetics of the University of Barcelona, and Drs. Dave Monk and Isidre Ferrer, from the same center, shows that the inheritance of small changes in DNA alters the expression of the PM20D1 gene and is associated with an increased risk of developing Alzheimer's disease.
Isotechnika Pharma Inc. and Paladin Labs Inc. announced today that they have submitted the dossier and received screening acceptance for VocleraTM (voclosporin) for approval in the Canadian market. VocleraTM is a novel immunosuppressive drug in the class of calcineurin inhibitors and is indicated for the treatment of moderate to severe psoriasis.
Natus Medical Incorporated today announced financial results for the three and nine months ended September 30, 2009.
› Verified 5 days ago
Charles Hearon, PHRAMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 302 University Pl, Durant, OK 74701 Phone: 580-920-1145 | |
Clint Morrison, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1801 Chukkahina, Durant, OK 74701 Phone: 580-920-2100 | |
Dr. Hali Marie Cornelison, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1231 N Washington Ave, Durant, OK 74701 Phone: 580-924-2903 Fax: 580-924-7337 | |
Miss Amanda Nicole Campo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 302 University Pl, Durant, OK 74701 Phone: 580-920-1145 | |
Matthew Cochran, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1801 Chukkahina, Durant, OK 74701 Phone: 580-920-2100 | |
Jessica O'connor, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1250 W Main St, Durant, OK 74701 Phone: 580-920-9945 |